Friday broker round-up

10th Jul 2020 13:26

(Sharecast News) - Ocado: Berenberg reiterates buy with a target price of 2,225.0p.

Read more

Monday broker round-up

20th Apr 2020 13:41

(Sharecast News) - Abcam: RBC Capital Markets upgrades to outperform with a target price of 1,300p.

Read more

Abcam warns on revenues as Covid-19 hits markets

20th Apr 2020 10:02

(Sharecast News) - Life sciences tools provider Abcam warned on full-year revenues on Monday as the Covid-19 pandemic began to take its toll across the group's markets.

Read more

Abcam 'uncertain' about coronavirus impact as China returns to work

9th Mar 2020 15:48

(Sharecast News) - Life science research tools company Abcam reported a 10.8% increase in total revenue increased 10.8% on a reported basis and 8.3% on a constant exchange rate basis in its interim results on Monday, to ?138.2m.

Read more

Abcam acquires Marker Gene Technologies

4th Mar 2020 10:26

(Sharecast News) - Life sciences group Abcam extended its assay and labelling capabilities on Wednesday with the acquisition of Marker Gene Technologies for an undisclosed sum.

Read more

ABCAM sees adjusted operating profit margin at lower end of guidance

10th Jan 2020 10:05

(Sharecast News) - Life science research tools supplier ABCAM warned on Friday that its full-year adjusted operating profit margins would come in at the lower end of its guidance range of 25.0-28.0% due to rapid investments into its newly-laid expansion plans.

Read more

Wednesday broker round-up

18th Dec 2019 13:25

(Sharecast News) - Cairn Energy: Morgan Stanley upgrades to overweight with a target price of 246p.

Read more

Abcam to buy Expedeon's proteomics and immunology businesses

11th Nov 2019 10:45

(Sharecast News) - Research tools supplier Abcam has agreed to buy Expedeon's proteomics and immunology businesses for €120m.

Read more

Monday broker round-up

16th Sep 2019 12:59

(Sharecast News) - Schroders: Jefferies downgrades to hold with a target price of 3,100p.

Read more

Thursday broker round-up

27th Jun 2019 11:16

(Sharecast News) - Rightmove: UBS downgrades to sell with a target price of 505p.

Read more

Monday broker round-up

25th Mar 2019 08:26

(Sharecast News) - Wood Group: Jefferies downgrades to underperform with a target price of 480p.

Read more

Abcam falls as outlook overshadows profit growth

4th Mar 2019 11:50

(Sharecast News) - Abcam's shares dropped sharply on Monday after stating its outlook will be impacted by "continued softness" in Japan, though the company reported growth for interim revenue and profits.

Read more

Abcam accquires Californian antibodies manufacturer

28th Jan 2019 08:35

(Sharecast News) - Antibody supplier Abcam has acquired Californian monoclonal antibodies manufacturer Calico Biolabs for an undisclosed amount.

Read more

Wednesday broker round-up

9th Jan 2019 12:26

(Sharecast News) - Nichols: Numis upgrades to add with a target price of 1,650p.

Read more

Double-digit revenue growth keeps Abcam on target

8th Jan 2019 08:17

(Sharecast News) - Abcam reported on Tuesday that it remains on track to meet full-year financial targets due to double digit revenue growth following the company's expansion in China.

Read more
2